During the past decade, Acibadem Maslak Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Acibadem Maslak Hospital" #1 sponsor was "Acibadem University" with 7 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Loxo Oncology, Inc." with 2 trials sponsored and "AO Foundation, AO Spine" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Acibadem Maslak Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Acibadem Maslak Hospital" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator, "Baskent University" with 1 trials as a collaborator and "Bursa Medicana Hospital" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Acibadem Maslak Hospital" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Cesarean Delivery" (2 trials), "Patient Satisfaction" (2 trials), "Advanced or Metastatic Gastric or Gastroesophageal Cancer" (1 trials) and "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Acibadem Maslak Hospital" in a lesser frequency.

Most popular intervention types in "Acibadem Maslak Hospital" are "Drug" (9 trials), "Procedure" (5 trials), "Device" (3 trials), "Diagnostic Test" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Cisplatin" (2 trials), "Entrectinib" (2 trials), "Lazertinib" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "Acibadem Maslak Hospital" are 14 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Acibadem Maslak Hospital". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Acibadem Maslak Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Acibadem Maslak Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".